TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17501997

Group type: COMPARATOR
Intervention: Standard protocol (VABB with 11G, 24 cores)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Extended protocol (VABB with 11G, 96 cores)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Extended protocol
Number of subjects: 107
Study: 15470331

Group type: EXPERIMENTAL
Intervention: St John's wort (300 mg 3 times daily)
Number of subjects: 12
Study: 11394559

Group type: EXPERIMENTAL
Intervention: Self‐administered, computer‐based intervention delivered in 15 brief weekly segments
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Self‐administered, computer‐based intervention
Number of subjects: 277
Study: 9743881

Group type: EXPERIMENTAL
Intervention: Intravenous oxytocin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intracervical prostaglandin E2 gel
Number of subjects: 45
Study: 8066102

Group type: EXPERIMENTAL
Intervention: Single intracervical application of PGE2 gel
Number of subjects: 32

Group type: COMPARATOR
Intervention: Repeated intracervical application of PGE2 gel (2 h apart)
Number of subjects: 32
Study: 2713518

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with adriamycin, vincristine and methotrexate (AVM), loco-regional radiotherapy and maintenance chemotherapy with vincristine, cyclophosphamide and 5 fluorouracil (VCF)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Reinforced protocol with five drugs: adriamycin, vincristine, cyclophosphamide, methotrexate, 5 FU (AVCMF)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Same schedule AVCMF, AVM, VCF with different radiotherapy schedule
Number of subjects: 210

Group type: COMPARATOR
Intervention: Radiotherapy alone with castration for pre-menopausal women (historical control group T)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with adriamycin, vincristine and methotrexate (AVM)
Number of subjects: 210
Study: 30209576

Group type: EXPERIMENTAL
Intervention: Propofol at a plasma concentration of 1000 ng/mL
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propofol 20 mg as a rescue antiemetic
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propofol group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study: 26821074

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve M-16V supplementation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 25904602

Group type: EXPERIMENTAL
Intervention: DBP concentration (highest quintile ≥7149.4 nmol/L)
Number of subjects: 885

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D (highest group ≥100 nmol/L)
Number of subjects: 885

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D (lowest group <25 nmol/L)
Number of subjects: 885
Study: 23343312

Group type: EXPERIMENTAL
Intervention: Social health program 'Sumida TAKE10!' (n=57), educational program incorporating 'TAKE10!® for Older Adults', once every 2 weeks for 3 months
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Social health program 'Sumida TAKE10!' (n=57)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (n=35)
Number of subjects: 92
Study: 20007305

Group type: COMPARATOR
Intervention: No-choice condition
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Premeal-choice condition
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: At-meal-choice condition
Number of subjects: 303

Group type: COMPARATOR
Intervention: No-choice condition (high-reactant children)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 303
Study: 19087569

Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (no HT)
Number of subjects: 31
Study: 16980806

Group type: EXPERIMENTAL
Intervention: Daily infant massage therapy by orphanage staff or volunteers for an average of 53 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 14626640

Group type: EXPERIMENTAL
Intervention: Folic acid and micronutrient combination supplementation (including vitamin B12 and B6)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flour fortification with vitamins B (folate, B12, B2, B6)
Number of subjects: 0
Study: 11099674

Group type: EXPERIMENTAL
Intervention: Apheresis (using Amicus, Autopheresis‐C, and CS‐3000)
Number of subjects: 10
Study: 8797135

Group type: EXPERIMENTAL
Intervention: Ramipril (5 mg oral dose)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg oral dose)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1319961

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 6241770

Group type: EXPERIMENTAL
Intervention: 20 ng hepatitis B surface antigen aluminium‐adsorbed vaccine, 3 doses of 40 micrograms over 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hepatitis B vaccine prior to surgery
Number of subjects: 0
Study: 31190122

Group type: EXPERIMENTAL
Intervention: Baseline serum PTH levels
Number of subjects: 5108

Group type: EXPERIMENTAL
Intervention: Baseline PTH of 0 pg/mL
Number of subjects: 5108

Group type: EXPERIMENTAL
Intervention: Baseline PTH of 69 pg/mL
Number of subjects: 5108

Group type: EXPERIMENTAL
Intervention: Baseline PTH of 58 pg/mL
Number of subjects: 5108
Study: 29203274

Group type: EXPERIMENTAL
Intervention: Modular Education Program for Children with Epilepsy and Their Parents
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (not participating in the modular education program)
Number of subjects: 184
Study: 26951097

Group type: EXPERIMENTAL
Intervention: I-125 permanent brachytherapy (PBT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 90
Study: 24768303

Group type: EXPERIMENTAL
Intervention: Ultrasound Group (n=75)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Landmark Group (n=75)
Number of subjects: 150
Study: 22712818

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 20088690

Group type: EXPERIMENTAL
Intervention: Face masks with hand hygiene
Number of subjects: 1437

Group type: EXPERIMENTAL
Intervention: Face masks alone
Number of subjects: 1437

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1437
Study: 18514105

Group type: EXPERIMENTAL
Intervention: OMS103HP (investigational drug product containing ketoprofen, amitriptyline, and oxymetazoline)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 16252346

Group type: EXPERIMENTAL
Intervention: Novel method using joint features of fractal dimension and entropies of texture edge co-occurrence matrix based on ultrasound images.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fisher linear classifier and support vector machine.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group of normal human volunteers.
Number of subjects: 36
Study: 12032039

Group type: EXPERIMENTAL
Intervention: Propofol 0.2 mg/kg followed by infusion at a rate of 2 mg.kg(‐1).h(‐1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: IV midazolam 5 mg
Number of subjects: 22
Study: 9706861

Group type: EXPERIMENTAL
Intervention: 25% metronidazole sustained release gel
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3% tetracycline ointment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Subgingival scaling and root planing
Number of subjects: 18
Study: 7604427

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2204251

Group type: EXPERIMENTAL
Intervention: Clomiphene (Clomid, Merrell)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 23137

Group type: EXPERIMENTAL
Intervention: Local application of aspirin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Local application of ethanol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Local application of indomethacin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Deionized water at 65°C
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Deionized water at 20°C
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 9α‐fludrocortisone
Number of subjects: 30
Study: 31151363

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 24
Study: 29624628

Group type: EXPERIMENTAL
Intervention: Screw-retained (full-crown abutment [FCA])
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cemented (zirconia crown [ZrC])
Number of subjects: 32
Study: 28446646

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 22528757

Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 23021318

Group type: EXPERIMENTAL
Intervention: Kids N Fitness(©), a 6-week program providing 45min of structured physical activity and a 45min nutrition education class for parents and children
Number of subjects: 251
Study: 21921285

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy with tamoxifen (20 mg/d for 5 years)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Sequential chemotherapy with tamoxifen (20 mg/d for 5 years)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy with tamoxifen
Number of subjects: 431

Group type: COMPARATOR
Intervention: Sequential chemotherapy with tamoxifen
Number of subjects: 431
Study: 18300336

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Aromatherapy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: EORTC QLQ‐C30 (Quality of Life Measure)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Semi-structured interviews
Number of subjects: 39

Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 39
Study: 17245184

Group type: EXPERIMENTAL
Intervention: I methylene blue (100, 200, 300, 400, 500, or 1000 microCi)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: I methylene blue (200 microCi)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: I methylene blue (various doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: I methylene blue (1 mCi)
Number of subjects: 12
Study: 14602191

Group type: EXPERIMENTAL
Intervention: HPMC K4MP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HPMC K100LVP
Number of subjects: 10
Study: 10718159

Group type: EXPERIMENTAL
Intervention: High environmental risk group (N = 92)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Low environmental risk group (N = 106)
Number of subjects: 198
Study: 8634210

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.2%
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sanguinarine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 18
Study: 1430705

Group type: EXPERIMENTAL
Intervention: Forced air heating (off1‐on2) from September 9 to 17, then thermostat set to 22 degrees C from 8 PM to 8 AM between September 18 and 25
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (off1‐off2) kept forced air heating off during the entire study period
Number of subjects: 51
Study: 3886496

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Computed Tomography
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both methods (Ultrasonography and Computed Tomography)
Number of subjects: 33
Study: 29992150

Group type: EXPERIMENTAL
Intervention: 2% Chamaemelum nobile gel
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 27401569

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP) monthly for 1 year
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP) once per school term
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP) within the past 30 days
Number of subjects: 810
Study: 24562806

Group type: EXPERIMENTAL
Intervention: Intracoronary bolus abciximab
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration
Number of subjects: 452

Group type: COMPARATOR
Intervention: No abciximab
Number of subjects: 452

Group type: COMPARATOR
Intervention: No aspiration
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: maxST residual at 60 min
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Qwave at 60 min
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Microvascular obstruction (MVO)
Number of subjects: 452
Study: 23017003

Group type: EXPERIMENTAL
Intervention: 0.05% sodium hypochlorite rinse
Number of subjects: 40

Group type: COMPARATOR
Intervention: Distilled water rinse (Control)
Number of subjects: 40
Study: 20658567

Group type: EXPERIMENTAL
Intervention: Low-volume resistance exercise (EX; n = 12) performed every other day at 80% of maximal for 14 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (CON; n = 5) with no exercise
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low-volume resistance exercise (EX; n = 12)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (CON; n = 5)
Number of subjects: 17
Study: 17825129

Group type: EXPERIMENTAL
Intervention: Tramadol ER (300 mg once daily for patients ≥ 75 years; 300-400 mg once daily for patients < 75 years)
Number of subjects: 919

Group type: EXPERIMENTAL
Intervention: Tramadol ER (open-label treatment after placebo-controlled studies)
Number of subjects: 919
Study: 15950149

Group type: EXPERIMENTAL
Intervention: Lateral decubitus position (LD)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Supine position (SP)
Number of subjects: 41
Study: 12898857

Group type: COMPARATOR
Intervention: Branched-chain amino acids (BCAA) concentrations measured by chromatography method with amino acid analyser AAA 400.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Plasma albumin concentration and urea for KT/V calculation determined by routine methods.
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Total amino acids and branched amino acids measured in study II.
Number of subjects: 67
Study: 10598760

Group type: EXPERIMENTAL
Intervention: Azelaic acid 20% cream
Number of subjects: 116

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 116
Study: 7554782

Group type: EXPERIMENTAL
Intervention: Diet rich in monounsaturated fatty acids (30% energy)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diet rich in polyunsaturated fatty acids (30% energy)
Number of subjects: 16
Study: 1941057

Group type: COMPARATOR
Intervention: Radiation to the abdomen and mantle (group AX3, 62 patients)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: MOPP chemotherapy (group A, 105 patients)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: No further treatment (AC6, 23 patients)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Radiotherapy to the abdomen and mantle (AX6, 48 patients)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy at 3-month intervals for 1 year (AC10, 26 patients)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Combined modality therapy (MOPP + radiation)
Number of subjects: 226
Study: 7174605

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27992063

Group type: EXPERIMENTAL
Intervention: Rituximab plus bendamustine (RB)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Rituximab plus hyperCVAD/MTX/ARAC (RH)
Number of subjects: 53
Study: 25340477

Group type: EXPERIMENTAL
Intervention: Family-based pulmonary rehabilitation (PR) program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional pulmonary rehabilitation (PR)
Number of subjects: 42
Study: 24664227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 1200 mg/d of CoQ10
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 2400 mg/d of CoQ10
Number of subjects: 600
Study: 21849198

Group type: EXPERIMENTAL
Intervention: 2 ml polidocanol sclerotherapy (30 mg/ml)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: 4 ml polidocanol sclerotherapy (30 mg/ml)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Overall treatment (1 to 4 treatments)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: 4 ml polidocanol sclerotherapy for larger hydroceles/spermatoceles
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: 2 ml polidocanol sclerotherapy for larger hydroceles/spermatoceles
Number of subjects: 224
Study: 19463396

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES)
Number of subjects: 4791

Group type: EXPERIMENTAL
Intervention: Guideline-recommended medications at 1 year (including aspirin, clopidogrel, ACE inhibitors, and statins)
Number of subjects: 4791
Study: 17462482

Group type: EXPERIMENTAL
Intervention: Treatment of interstitial cystitis (IC) in males
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diagnosis and treatment of chronic nonbacterial prostatitis (CP)
Number of subjects: 0
Study: 15350319

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 11452676

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 9684851

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg twice daily
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 7873233

Group type: EXPERIMENTAL
Intervention: penicillin + metronidazole
Number of subjects: 40

Group type: COMPARATOR
Intervention: penicillin
Number of subjects: 40
Study: 2896666

Group type: EXPERIMENTAL
Intervention: Clorazepate
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 29955924

Group type: EXPERIMENTAL
Intervention: Intervention Phase I (focused education program and implementation of treatment bundle)
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Intervention Phase II (provision of resources to implement treatment bundle)
Number of subjects: 1594

Group type: COMPARATOR
Intervention: Pre-intervention
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Intervention I
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Intervention II
Number of subjects: 1594
Study: 27932101

Group type: EXPERIMENTAL
Intervention: Nephrectomy of failed graft (Group A)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Retained failed graft (Group B)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Graft survival (both groups)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Patient survival (both groups)
Number of subjects: 63
Study: 26431823

Group type: EXPERIMENTAL
Intervention: Low-dose rAAV.sFLT-1 (1×10^10 vector genomes)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High-dose rAAV.sFLT-1 (1×10^11 vector genomes)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (no gene therapy treatment)
Number of subjects: 9
Study: 23259880

Group type: EXPERIMENTAL
Intervention: Pre-incisional local wound infiltration with 1% lidocaine
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Post-incisional local wound infiltration with 1% lidocaine
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Combined pre- and post-incisional local wound infiltration with 1% lidocaine
Number of subjects: 281
Study: 22212257

Group type: EXPERIMENTAL
Intervention: Isometric leg extension
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dynamic leg extension
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Resting muscle tone assessment
Number of subjects: 17
Study: 19057117

Group type: EXPERIMENTAL
Intervention: CSA scale measurement for operators with field-dependent cognitive styles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSA scale measurement for operators with field-independent cognitive styles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control-display pairing tasks for both cognitive styles
Number of subjects: 0
Study: 16539087

Group type: EXPERIMENTAL
Intervention: Participant-developed consent document
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Investigator-developed consent document
Number of subjects: 1092
Study: 14579214

Group type: EXPERIMENTAL
Intervention: Intracoronary nicardipine (0.1 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intracoronary nitroglycerin (20 microg)
Number of subjects: 32
Study: 11517843

Group type: EXPERIMENTAL
Intervention: Psychological intervention (standard education plus stress-management skills)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard education about risk for breast cancer (control group)
Number of subjects: 20
Study: 9625082

Group type: EXPERIMENTAL
Intervention: High leptin concentrations in women with no obese parent
Number of subjects: 49

Group type: COMPARATOR
Intervention: High leptin concentrations in women with at least one obese parent
Number of subjects: 49

Group type: COMPARATOR
Intervention: Changes in energy and fat intakes
Number of subjects: 49
Study: 7512402

Group type: EXPERIMENTAL
Intervention: Intraprostatic spiral treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (observation)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Transurethral prostatectomy (TURP)
Number of subjects: 9
Study: 3279023

Group type: EXPERIMENTAL
Intervention: 75 mg/day trimipramine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 150 mg/day trimipramine
Number of subjects: 34
Study: 30593980

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 28301619

Group type: EXPERIMENTAL
Intervention: HBP Lotion, 0.05% applied twice daily for 14 days
Number of subjects: 443

Group type: COMPARATOR
Intervention: VEH (vehicle control)
Number of subjects: 443
Study: 26468792

Group type: EXPERIMENTAL
Intervention: Face to face technique
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Back to back technique
Number of subjects: 21
Study: 23602678

Group type: EXPERIMENTAL
Intervention: Closed vitrification system
Number of subjects: 75

Group type: COMPARATOR
Intervention: Open vitrification system
Number of subjects: 75